Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    23471131 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
Condition: Kidney Disease
Interventions: Drug: Lanthanum Carbonate;   Other: 900 mg Phosphate Diet;   Drug: LC Placebo;   Other: Ad Libitum Diet

Study has passed its completion date and status has not been verified in more than two years.